These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10793222)

  • 21. Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue.
    McDonald RL; Vaughan PF; Beck-Sickinger AG; Peers C
    Neuropharmacology; 1995 Nov; 34(11):1507-14. PubMed ID: 8606797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists.
    Parker EM; Babij CK; Balasubramaniam A; Burrier RE; Guzzi M; Hamud F; Mukhopadhyay G; Rudinski MS; Tao Z; Tice M; Xia L; Mullins DE; Salisbury BG
    Eur J Pharmacol; 1998 May; 349(1):97-105. PubMed ID: 9669502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of fluorescent nonpeptidic neuropeptide Y receptor ligands: analogues of the quinazoline-type anti-obesity Y5 antagonist CGP 71683A.
    Li L; Mayer M; Schneider E; Schreiber E; Bernhardt G; Peng S; Buschauer A
    Arch Pharm (Weinheim); 2003 Dec; 336(12):585-90. PubMed ID: 14677152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor.
    Schober DA; Van Abbema AM; Smiley DL; Bruns RF; Gehlert DR
    Peptides; 1998; 19(3):537-42. PubMed ID: 9533642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of stimulated cyclic AMP production by multiple neuropeptide Y receptors in the rat brainstem.
    Ny L; Grundemar L
    Neurosci Lett; 1997 Jan; 221(2-3):113-6. PubMed ID: 9121677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats.
    Turnbull AV; Ellershaw L; Masters DJ; Birtles S; Boyer S; Carroll D; Clarkson P; Loxham SJ; McAulay P; Teague JL; Foote KM; Pease JE; Block MH
    Diabetes; 2002 Aug; 51(8):2441-9. PubMed ID: 12145156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
    DiMaggio DA; Farah JM; Westfall TC
    Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NPY receptors and opioidergic system are involved in NPY-induced feeding in goldfish.
    de Pedro N; López-Patiño MA; Guijarro AI; Pinillos ML; Delgado MJ; Alonso-Bedate M
    Peptides; 2000 Oct; 21(10):1495-502. PubMed ID: 11068096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
    Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
    Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.
    Krause J; Eva C; Seeburg PH; Sprengel R
    Mol Pharmacol; 1992 May; 41(5):817-21. PubMed ID: 1316999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
    Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
    Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropeptide Y Y5 receptors suppress in vitro spontaneous epileptiform bursting in the rat hippocampus.
    Nanobashvili A; Woldbye DP; Husum H; Bolwig TG; Kokaia M
    Neuroreport; 2004 Feb; 15(2):339-43. PubMed ID: 15076765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
    Guo H; Castro PA; Palmiter RD; Baraban SC
    J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.
    Galas L; Tonon MC; Beaujean D; Fredriksson R; Larhammar D; Lihrmann I; Jegou S; Fournier A; Chartrel N; Vaudry H
    Endocrinology; 2002 May; 143(5):1686-94. PubMed ID: 11956150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological characterization of the cloned neuropeptide Y y(6) receptor.
    Mullins DE; Guzzi M; Xia L; Parker EM
    Eur J Pharmacol; 2000 Apr; 395(2):87-93. PubMed ID: 10794812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
    Gehlert DR; Schober DA; Morin M; Berglund MM
    Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor.
    Parker SL; Kane JK; Parker MS; Berglund MM; Lundell IA; Li MD
    Eur J Biochem; 2001 Feb; 268(4):877-86. PubMed ID: 11179953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.